Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer
Open Access
- 22 August 2011
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 109 (7), 988-993
- https://doi.org/10.1111/j.1464-410x.2011.10514.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Long-term Survival After Radical Prostatectomy for Men With High Gleason Sum in Pathologic SpecimenUrology, 2010
- Metastasis After Radical Prostatectomy or External Beam Radiotherapy for Patients With Clinically Localized Prostate Cancer: A Comparison of Clinical Cohorts Adjusted for Case MixJournal of Clinical Oncology, 2010
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Pathologic stage T2a and T2b prostate cancer in the recent prostate‐specific antigen era: Implications for unilateral ablative therapyThe Prostate, 2008
- Impact of prostate‐specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8–10 cancersBJU International, 2007
- Prostate cancer‐specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high‐risk factorsCancer, 2007
- Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005Urology, 2007
- Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice GuidelineJournal of Clinical Oncology, 2007
- Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinomaBJU International, 2006
- Time Trends in Clinical Risk Stratification for Prostate Cancer: Implications for Outcomes (Data From CaPSURE)Journal of Urology, 2003